Fingerprint
Dive into the research topics of 'Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer
Tien Hoang, Kyungmann Kim, Joseph Merchant, Anne M. Traynor, James McGovern, Kurt R. Oettel, Fredrico A. Sanchez, Harish G. Ahuja, Thomas A. Hensing, Martha Larson, Joan H. Schiller
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations